The proinflammatory pathway mediated by TLR4 is a crucial link in the pathogenesis of neonatal NEC, and inhibition of the TLR4-mediated inflammatory pathway may be a new therapy for the prevention and therapy of neonatal NEC [29, 30]. This evidence concerns the gene TLR4 and necrotizing enterocolitis.